DSW Ventures logo

DSW Ventures

Europe, Manchester, United Kingdom, Manchester

Description

DSW Ventures is a prominent early-stage venture capital firm based in Manchester, United Kingdom, known for its strong focus on high-growth businesses located outside of London. As part of the Dow Schofield Watts group, the firm leverages a broad network and deep expertise to support promising startups across various sectors. DSW Ventures is backed by a mix of institutional and individual investors, enabling it to provide crucial capital to nascent companies aiming for significant scale. Their strategy emphasizes supporting the vibrant entrepreneurial ecosystems in UK regions beyond the capital.

The firm primarily targets companies seeking EIS-qualifying funding rounds, making them an attractive partner for UK-based startups. DSW Ventures typically invests between £250,000 and £1,000,000 as a first cheque. These investments are usually part of larger funding rounds that can range up to £5,000,000 in total, demonstrating their capacity to participate in substantial early-stage raises. While sector-agnostic, their portfolio frequently includes companies in technology, software, B2B services, manufacturing, and consumer sectors, reflecting a diverse investment appetite. They prioritize strong management teams, disruptive business models, and a clear path to exit.

Since its inception, DSW Ventures has established a robust track record, having deployed over £30 million across more than 20 businesses. This significant capital deployment underscores their commitment to fostering innovation and growth within the UK's regional economies. Their hands-on approach and strategic guidance aim to help portfolio companies navigate the challenges of early-stage development and achieve their full potential. The firm's consistent activity and substantial investment figures position it as a key player in the UK's regional venture capital landscape.

Investor Profile

DSW Ventures has backed more than 25 startups, with 6 new investments in the last 12 months alone. The firm has led 19 rounds, about 76% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Angel, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United Kingdom, United States.
  • Strong thematic focus on Biotechnology, E-Commerce, Software.
  • Led 5 rounds in the past year.
  • Typical check size: $315K – $1.3M.

Stage Focus

  • Seed (48%)
  • Angel (16%)
  • Pre Seed (16%)
  • Series Unknown (12%)
  • Series A (8%)

Country Focus

  • United Kingdom (88%)
  • United States (12%)

Industry Focus

  • Biotechnology
  • E-commerce
  • Software
  • Marketing
  • Manufacturing
  • Media And Entertainment
  • Therapeutics
  • Service Industry
  • Market Research
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DSW Ventures frequently co-invest with?

Boundary Capital Partners LLP
Europe, England, United Kingdom, London
Co-Investments: 1
MP
Europe, Warwickshire, United Kingdom, Henley In Arden
Co-Investments: 1
Co-Investments: 1
Business Growth Fund
Europe, England, United Kingdom, London
Co-Investments: 1
Aston University
Europe, Birmingham, United Kingdom, Birmingham
Co-Investments: 1
Mercia Fund Managers
Europe, Warwickshire, United Kingdom, Henley In Arden
Co-Investments: 1
QUBIS
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 2
NC
Europe, East Sussex, United Kingdom, Wadhurst
Co-Investments: 1
Northstar Ventures
Europe, Newcastle upon Tyne, United Kingdom, Newcastle Upon Tyne
Co-Investments: 5
SFC Capital
Europe, Cheshire, United Kingdom, Northwich
Co-Investments: 2

Which angels does DSW Ventures often collaborate with?

Shared Deals: 1
HD
Europe, Kirklees, United Kingdom, Huddersfield
Shared Deals: 1

What are some of recent deals done by DSW Ventures?

RoxFit

York, Pennsylvania, United States

RoxFit is the best HYROX workout tracker for preparation and performance on race day.

FitnessWellness
Pre SeedMay 28, 2025
Amount Raised: $1,077,524
Fireflai

Manchester, Manchester, United Kingdom

Fireflai uses advanced AI and data science to help businesses streamline vast and inconsistent product datasets.

Cloud Data ServicesGenerative AI
Pre SeedMar 31, 2025
Amount Raised: $537,972
StimOxyGen

Coleraine, Coleraine, United Kingdom

StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors.

Clinical TrialsMedicalNanotechnologyTherapeutics
Series UnknownMar 11, 2025
Amount Raised: $1,941,632
Dia Beta Labs

Belfast, Belfast, United Kingdom

Dia Beta Labs is the research group's official commercial vehicle, advancing lead assets into late-stage preclinical development.

BiotechnologyDiabetesTherapeutics
SeedDec 9, 2024
Amount Raised: $1,529,910
TheNextLevel

Manchester, Manchester, United Kingdom

TheNextLevel assists in our design and can produce a gorgeous native mobile app for iOS and Android that precisely matches your vision.

Developer PlatformSoftware
Pre SeedOct 3, 2024
4D Biomaterials

Nottingham, Nottingham, United Kingdom

4D Biomaterials manufactures polymer resins for 3D-printing high resolution biodegradable medical devices.

BiotechnologyHealth CareManufacturingMedical Device
Series AJul 25, 2024
Amount Raised: $4,380,580
Glen Clova Scientific

Scotland, Indiana, United States

Glen Clova Scientific is a company that developing a new gneration of active biological drugs.

BiopharmaBiotechnologyHospital
SeedApr 24, 2024
Amount Raised: $4,983,691
InvenireX

Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom

InvenireX is a biotechnology company that offers molecular diagnostics services.

BiotechnologyHealth Diagnostics
SeedMar 18, 2024
Amount Raised: $636,344
The Insights Family

Manchester, Manchester, United Kingdom

The Insights Family is the global leader in kids, parents, and family market intelligence. Working across 22 markets with 100+ clients.

Market ResearchMarketing
Series UnknownJan 25, 2024
Amount Raised: $7,115,810
Mesenbio

Newyork, Argyll and Bute, United Kingdom

Mesenbio is a preclinical biopharmaceutical business based at the University of York.

BiotechnologyTherapeutics
SeedJan 9, 2024
Amount Raised: $1,779,681